In this episode of the MAPS Canada podcast, host Osheen Dayal is joined by Jagpaul Kaur Deol — a neuropharmacologist, researcher and MAPS Canada board member — to discuss the essential science of psychedelic safety. We move beyond the hype to look at how these substances actually interact with the body and mind, and why a "one-size-fits-all" approach doesn’t work in this field.

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada.

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Dr. Capler outlines how MAPS Canada is working to make complex research, policy developments, and therapeutic frameworks more accessible to a wide range of audiences. From research presentations and webinars to podcasts and online courses, the conversation explores how different educational formats are designed to meet people where they are.

The discussion also highlights the importance of community engagement, psychedelic safety and risk reduction, and diverse perspectives in shaping a responsible approach to psychedelic education, offering insight into how informed public discourse can support the future of the field.

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada.

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

In this episode, Dr. Pamela Kryskow joins host Kyle Sittek-Lumsden to explore the role of psychedelic-assisted therapy in the treatment of substance use disorders. Drawing on her clinical experience, Dr. Kryskow discusses how addiction is increasingly understood as a response to trauma, emotional pain, and disconnection, rather than a moral failing. The conversation highlights how addressing root causes rather than symptoms alone can lead to meaningful and lasting change.

The discussion also examines current treatment approaches in Canada, including ketamine, psilocybin, and MDMA-assisted therapies, as well as the importance of preparation, integration, and community support. Dr. Kryskow reflects on the evolving landscape of psychedelic medicine, ongoing barriers to access, and what a more effective, patient-centered system of care could look like in the future.

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada.

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Topics of discussion include:

Why intention matters
When and how to set it
How to prepare the day before
The importance of mindset, space, and context
Finding the right guide, therapist, or sitter
Safety, support, and ethical facilitation
Preparation isn’t optional — it’s part of the medicine.

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada.

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Drawing from her experience as a First Nations woman, counsellor, and co-founder of Sacred Circle Wellness, Francine reflects on the medicine wheel and the interconnection of physical, emotional, mental, and spiritual health. She shares how sacred medicines offered a reminder to a return to balance, self-care, cultural practice, and belonging.

This conversation moves beyond individual wellness into collective healing — examining how relationship, reciprocity, and cultural remembrance are essential foundations for true wellbeing.

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada.

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Many ways to engage, join our community:

https://www.x.com/mapscanada
https://www.instagram.com/mapscanada
https://www.facebook.com/MAPSCanada

MAPSCanada #Psychedelic #Research #Medicine #Therapy #Breathwork #PsychedelicTherapy #TraumaHealing #MedicineWithin

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Many ways to engage, join our community:

https://www.x.com/mapscanada

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Many ways to engage, join our community:

/ mapscanada

/ mapscanada

/ mapscanada

MAPSCanada #Psychedelic #Research #Medicine #Therapy

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Many ways to engage, join our community:

https://twitter.com/mapscanada
https://www.instagram.com/mapscanada/
https://www.facebook.com/MAPSCanada/

MAPSCanada #Psychedelic #Research #Medicine #Therapy

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Many ways to engage, join our community:

https://twitter.com/mapscanada
https://www.instagram.com/mapscanada/
https://www.facebook.com/MAPSCanada/

MAPSCanada #Psychedelic #Research #Medicine #Therapy

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Many ways to engage, join our community:

https://twitter.com/mapscanada
https://www.instagram.com/mapscanada/
https://www.facebook.com/MAPSCanada/

MAPSCanada #Psychedelic #Research #Medicine #Therapy

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Many ways to engage, join our community:

https://twitter.com/mapscanada
https://www.instagram.com/mapscanada/
https://www.facebook.com/MAPSCanada/

MAPSCanada #Psychedelic #Research #Medicine #Therapy

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Many ways to engage, join our community:

https://twitter.com/mapscanada
https://www.instagram.com/mapscanada/
https://www.facebook.com/MAPSCanada/

MAPSCanada #Psychedelic #Research #Medicine #Therapy #Psychedelics #RacialTrauma #MentalHealth #SafeSpaces #TherapistTraining

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Many ways to engage, join our community:

https://twitter.com/mapscanada
https://www.instagram.com/mapscanada/
https://www.facebook.com/MAPSCanada/

MAPSCanada #Psychedelic #Research #Medicine #Therapy #Psychedelics #RacialTrauma #MentalHealth #SafeSpaces #TherapistTraining

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Many ways to engage, join our community:

/ mapscanada

/ mapscanada

/ mapscanada

MAPSCanada #Psychedelic #Research #Medicine #Therapy #drugchecking #harmreduction #testbeforeyouingest

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

MAPSCanada #Psychedelic #Research #Medicine #Therapy #OsheenInterviews #psychedelictreatment #psychedelictherapy #mapscanada #research #books

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Many ways to engage, join our community:

/ mapscanada

/ mapscanada

/ mapscanada

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Many ways to engage, join our community:

/ mapscanada

/ mapscanada

/ mapscanada

MAPSCanada #Psychedelic #Research #Medicine #Therapy #HarmReduction #CannabisResearch #PublicHealth #BCCSU #SubstanceUse #GenderEquity #HousingCrisis #AddictionScience #CannabisScience #HarmReduction #OverdosePrevention #OpioidCrisis #DTES #BCCSU #SubstanceUseResearch #DrugPolicy #MAPSCanada #PsychedelicScience #PublicHealthCanada

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Many ways to engage, join our community:

/ mapscanada

/ mapscanada

/ mapscanada

MAPSCanada #Psychedelic #Research #Medicine #Therapy #PsychedelicSafety #MAPSCanadaPod #PsychedelicHealing #HarmReduction #Podcast

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then.

MAPS Canada was founded as a sister organization to MAPS in 2011, and is a registered Canadian non-profit organization. Based in Vancouver and with hundreds of volunteers from across Canada, MAPS Canada is moving forward to become the leading Canadian source of information, resources and advocacy regarding psychedelic medicine and related clinical research, education, and public policy.

Learn More at https://mapscanada.org/about/

MAPS Canada is entirely funded by public donation and your support really makes a difference. Find out about all the ways you can support MAPS Canada’s mission by visiting our donation link https://mapscanada.org/donate/

Many ways to engage, join our community:

/ mapscanada

/ mapscanada

/ mapscanada

Dr. Zachary Walsh, a leading clinical psychologist and researcher, explores the therapeutic potential of psychedelics in this episode, focusing on psilocybin-assisted psychotherapy for opioid titration and his involvement in the Microdose.me study.

He explains the distinction between cannabis, used for symptom relief, and psychedelics and discusses the controversial link between cannabis and psychosis, emphasizing the need for further research.

Join us as he shares insights on the evolving role of clinicians in supporting patients interested in microdosing and the challenges of integrating psychedelic medicine into healthcare!

Donate to MAPS Canada at https://mapscanada.org/donate/

Rachel Harris, PhD, is the author of "Swimming in the Sacred: Wisdom from the Psychedelic Underground" and "Listening to Ayahuasca." A psychologist who has been in private practice for 40 years, she spent 10 years in an academic research department where she published more than 40 scientific studies in peer-reviewed journals and received a National Institutes of Health New Investigator’s Award. Rachel splits her time between an island in Maine and the San Francisco Bay Area.

Visit her online at http://www.swimminginthesacred.com

Donate to MAPS Canada at https://mapscanada.org/donate/

Michael is a writer, podcast host, speaker, community-builder, and wonder junkie holding a B.A. in Journalism.

Check it out at https://thirdeyedrops.com/
And consider donating to MAPS Canada at https://mapscanada.org/donate/

He was a speaker at Psychedelic Science 2023, the world biggest ever conference on psychedelics, and he has been closely following the movement from it's beginnings.

In this podcast, hear Don Lattin's perspective on the rise of psychedelic churches, the NYU-John Hopkins study on religious clergy members experience after two psilocybin sessions

Find more about Don Lattin here: www.donlattin.com

More information on Don Lattin's latest book God on Psychedelics: https://apocryphilepress.com/book/psychedelics/

Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS) founded in 1986.

MAPS is a nonprofit organization that provides public education, research and policy reform towards the legal, responsible and evidence–based use of psychedelics.

Rick has dedicated 50 years of his life towards this mission and MAPS now leads the way towards creating legal context for the beneficial uses of psychedelics on an international scale.

We are MAPS Canada, a sister organization to the U.S. based MAPS.

MAPS needs MDMA therapists! Learn more about becoming an MDMA therapist here: https://mapsbcorp.com/training/

Check out the biggest psychedelic conference ever, Psychedelic Science 2023: https://psychedelicscience.org/

Dennis McKenna has conducted research in ethnopharmacology for over 40 years. He is a founding board member of the Heffter Research Institute and was a key investigator on the Hoasca Project, the first biomedical investigation of ayahuasca. He was part of the original Scientific Strategy Team at Shaman Pharmaceuticals in the early 90s. He is the younger brother of Terence McKenna.

From 2000 to 2017, he taught courses on Ethnopharmacology and Plants in Human affairs as an adjunct Assistant Professor in the Center for Spirituality and Healing at the University of Minnesota. In the spring of 2019, in collaboration with colleagues in Canada and the US, he incorporated a new non-profit, the McKenna Academy of Natural Philosophy. In collaboration with colleagues he organized two landmark conferences in 2017 and 2022, the Ethnopharmacologic Search for Psychoactive Drugs (see ESPD50.com and ESPD55.com) He emigrated to Canada in the spring of 2019 together with his wife Sheila, and now resides in Abbotsford B.C.

Learn more about the McKenna Academy, Biognosis and how you can support, here: https://mckenna.academy/

In this MAPS Canada Podcast episode, Luc Briedé-Cooper and Sabrina Ramkellawan sit down with Dr. Olga Chernoloz a Ukrainian researcher based in Canada.

Become part of the psychedelic movement by donating at: https://mapscanada.org/donate/

Dr. Chernoloz has extensive experience in research of psychoactive compounds for mental health and
neurological applications.

She is a scientific advisor to Psychedelics Studies Research Group at University of Toronto and has held a number of roles in clinical trial management, drug development, biotech, and pharmaceutics.

Kayla Breelove Carter works with individuals and organizations to increase their awareness and understanding of trauma, racial trauma, and adverse childhood experiences. With over ten years of clinical experience, Kayla specializes as well in nutritional psychology and psychedelic assisted therapy.

As a clinical supervisor for those seeking licensing in New Brunswick and Nova Scotia, Kayla also dedicates her time in supporting graduate students through Breelove’s weekly free counselling clinic and community counselling program, where individuals seeking counselling therapy can engage in one on one mental health counselling for free.

Become part of the psychedelic movement by donating at https://mapscanada.org/donate/

Erika’s research focuses mainly on the history of medicine, health and social justice, and of course, the history of psychedelics in psychiatry. She’s taught classes on the history of medicine and psychiatry, social justice and gender equality in medicine, and eugenics. She’s also written on women’s health in other aspects of Canadian health care. More recently, Erika’s research focuses on women in the history of psychedelic psychiatry. She highlights the importance of thinking about the intersections of gender in psychedelics and incorporating new voices and discussions about gender considerations in the development of psychedelic therapy.

Links:

• Chachruna Institute for Psychedelic Plant Medicines
• Graphic Novel—"Wonder Drug: LSD in the Land of Living Skies”
• MAPS Special Bulletin—Women and Psychedelics
• Women on Psychedelics
• Société Psychédélique Française - Webinar ‘Gender, Women and Psychedelics’

MAPS Canada is a registered non-profit; we rely on the generosity of our supporters to fund our life-changing research. Please visit mapscanada.org/donate to become a monthly donor or to make a one-time donation today!

Feedback? Feel free to email us at: podcast@mapscanada.org

This episode was produced and edited by Brendon Campbell. Original music and audio engineering by Andrew Illmann.

We’ll be back on July 19th, with an episode featuring Canadian Historian, Dr. Erika Dyck. Erika joins us to discuss her research on Canada’s history with psychedelics, the history of women and psychedelics, and some of the exciting projects she is collaborating on with individuals from around the world, alongside the Chacruna Institute for Psychedelic Plant Medicines.

This episode was produced and edited by Brendon Campbell. Original music and audio engineering by Andrew Illmann.

MAPS Canada is a registered non-profit; we rely on the generosity of our supporters to fund our life-changing research. Please visit mapscanada.org/donate to become a monthly donor or to make a one-time donation today!

Feedback? Feel free to email us at: podcast@mapscanada.org

Did you know Canada was once the leading country in psychedelic research? Beginning in the late-1940s, Canada’s first so-called socialist provincial government in Saskatchewan set out to improve the state of mental health care with research at the Weyburn Mental Hospital. Over the course of the 1950s, groundbreaking research with LSD and mescaline was conducted at Weyburn and LSD made its way to British Columbia which became home to the most prominent mental healthcare facility in the world during the 1960s. In this episode, we deliver a behind-the-scenes look at the introduction of LSD and peyote into Canada and the story behind the fascinating scientists and researchers that pioneered psychedelic research in the realm of psychiatry, while also advocating Indigenous Peoples and their cultural rights to peyote.

This episode was produced and edited by Brendon Campbell. It was researched and written by Jaipreet Mattu, Sean Hallam, Rebecca Troock, Sidath Rankaduwa, Monica Lau, Ross Crockford, and Bob Sybydlo. Readings by Sean Hallam, Jaipreet Mattu, and Brendon Campbell. Original music and audio engineering by Andrew Illmann. We’d like to give a special thanks to Ross Crockford for providing research material and helping us make this episode come alive.

MAPS Canada is a registered non-profit; we rely on the generosity of our supporters to fund our life-changing research. Please visit mapscanada.org/donate to become a monthly donor or to make a one-time donation today!

Feedback? Feel free to email us at: podcast@mapscanada.org

Sources:

Bradford, T., & Dyck, E. (2012). Peyote on the Prairies: Religion, Scientists, and Native-Newcomer Relations in Western Canada. Journal of Canadian Studies, 46(1), 28-52

Brown, J.E. Introduction to LSD Experience, December 8, 1957. Cathedral of the Holy Rosary. Letter.

Cameron, D. (Executive Producer) (1960). 1960 Saskatchewan election: Tommy Douglas' medicare plan dominates the 1960 election campaign [Television Broadcast]. CBC News Magazine. CBC Television.

Crockford, R. (2001a). B.C.’S Acid Flashback. Vancouver Sun. http://www.rave.ca/en/news_info/142625/canada/. Accessed 31 January 2021.

Crockford, R. (2001b). Dr. Yes. Western Living. December 2021 issue.

Dyck, E. (2019). Psychedelic Research in 1950 Saskatchewan. In The Canadian Encyclopedia. https://www.thecanadianencyclopedia.ca/en/article/psychedelic-research-in-1950s-saskatchewan. Accessed 25 January 2021.

Dyck, E. (2012). Psychedelic Psychiatry: LSD on the Canadian Prairies. Winnipeg: University of Manitoba Press.

Dyck, E. (2007). The History of LSD - The Original Psychedelic Drug: Acid trip. Biochemist, 29(2), 20-23.

Dyck, E. (2006). Hitting Highs at Rock Bottom’: LSD Treatment for Alcoholism, 1950–1970. Social History of Medicine, 19(2), 313–329.

Hofmann, A. (1978). LSD: My Problem Child and Insights/Outlooks. Oxford University Press.

Huxley, A. (1954). The Doors of Perception. Harper & Row.

Osmond, H. (Performer), Littlefield, C. (Director). (2002). Hofmann’s Potion. [Documentary]. Retrieved from https://www.nfb.ca/film/hofmanns_potion/. Accessed 5 March 2021.

Metcalfe, B. (1959, Sep 1). The Experience: Moment of truth's alarming. The Province, 1.

Sagi, D. (1956, Oct 13). White Men Witness Indian Peyote Rites. Saskatoon Star-Pheonix, 15.

This episode was produced and edited by Brendon Campbell. Original music and audio engineering by Andrew Illmann.

We’ll be back on June 21st with our first Canadian History of Psychedelics episode!

MAPS Canada is a registered non-profit; we rely on the generosity of our supporters to fund our life-changing research. Please visit mapscanada.org/donate to become a monthly donor or to make a one time donation today!

Feedback? Feel free to email us at: podcast@mapscanada.org

Links:

• Self-blinded microdosing paper: Self-blinding citizen science to explore psychedelic microdosing
• MDMA imaging study Dr. Balázs mentions he critiqued at a conference in 2016: The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity
• Published reinterpretation of those MDMA imaging results: Are ecstasy induced serotonergic alterations overestimated for the majority of users?
• MyDelica app: MyDelica | Charting a path to wellness
• Ayelet Waldman’s book on microdosing: A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My Life

This episode was produced and edited by Brendon Campbell. It was written by Sidath Rankaduwa, Jaipreet Mattu, Monica Lau, and Brendon Campbell. Original music and audio engineering by Andrew Illmann.

References & Sources:

Bradford, T., & Dyck, E. (2012). Peyote on the Prairies: Religion, Scientists, and Native-Newcomer Relations in Western Canada. Journal of Canadian Studies, 46(1), 28-52

Carhart-Harris, R.L. (2018). How do Psychedelics Work? Current Opinion in Psychiatry, 32(1), 16-21.

Dobkin de Rios, M., & Janiger, O. (2003). LSD, spirituality, and the creative process: Based on the groundbreaking research of Oscar Janiger, MD. Inner Traditions Bear and Company.

Dyck, E. (2019). Psychedelic Research in 1950 Saskatchewan. In The Canadian Encyclopedia. https://www.thecanadianencyclopedia.ca/en/article/psychedelic-research-in-1950s-saskatchewan. Accessed 25 January 2021.

Dyck, E. (2012). Psychedelic Psychiatry: LSD on the Canadian Prairies. Winnipeg: University of Manitoba Press.

Griffiths, R.R., Johnson, M.W., Carducci, M.A., Umbricht, A., Richards, W.A., Richards, B.D., Cosimano, M.R., & Klinedinst, M.A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology, 30(12), 1181-1197.

Hofmann, A. (1994). High Times Magazine [Interview Recording]. Retrieved from https://www.youtube.com/watch?v=jN6rYHAZ30c

Hofmann, A. (1978). LSD: My Problem Child and Insights/Outlooks. Oxford University Press.

Osmond, H. (Performer), Littlefield, C. (Director). (2002). Hofmann’s Potion. [Documentary]. Retrieved from https://www.nfb.ca/film/hofmanns_potion/

Huxley, A. (1954). The Doors of Perception. Harper & Row.

Lau, M. (2021). [W-wait… Did you say psychedelics were used in psychiatry?] [Speech audio recording].

Leary, T. (1966). Turn on, tune in, drop out. World Heritage Encyclopedia.

Leary, T., Metzner, R., & Alpert, R. (1964). The Psychedelic Experience: A Manual Based on the Tibetan Book of the Dead. Zihuatanejo Project. (n.p.)

Johnson, M.W., Garcia-Romeu, A., & Griffiths, R., (2017). Long-term Follow-up of Psilocybin-facilitated Smoking Cessation. American Journal of Alcohol Abuse, 43(1), 55-60.

May, P. (2014). Lysergic Acid Diethylamide (LSD). In P.M. & S.C. (Eds.), Molecules That Amaze Us (pp. 293-303). Taylor and Francis Group, LLC.

Multidisciplinary Association of Psychedelic Studies. (2021). Welcome to MAPS Canada. https://mapscanada.org/

Nichols, D.E. (2016). Psychedelics. Pharmacological Reviews, 68, 264-355.

Passie, T., Halpern, J.H., Stichtenoth, D.O., Emrich, H.M., & Hintzen, A. (2008). The Pharmacology of Lysergic Acid Diethylamide: A Review. CNS Neuroscience and Therapeutics, 14(4), 295-314.

Sessa, B. (2012). The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society. Muswell Hill Press.

Stevens, J. (1987). Storming heaven: LSD and the American dream. New York: Grove Press.

Wasson, G.R., Hoffman, A., & Ruck, C.A.P. (2008). The Road to Eleusis: Unveiling the Secret of the Mysteries. North Atlantic Books.